Uncategorized

Harbour BioMed Announces Completion of Phase 2 Study in China of HBM9036 In Patients With Moderate-to-Severe Dry Eye Disease

by  •  • 0 Comments
CAMBRIDGE, Mass. & ROTTERDAM, The Netherlands & SHANGHAI--(BUSINESS WIRE)--Harbour BioMed Announces Completion of Phase 2 Study in China of HBM9036 in Patients with Moderate-to-Severe Dry Eye Disease

Full Story →